Biomarkers for Neurological Disease and Dementia
Aries Biotech and Neurovations are merging their expertise in research and development to measure biomarkers of dementia. Additional information for Neurovations, a leader in patient care, medical devices, and clinical research may be found at https://neurovations.com/.
To learn how we can augment your needs, visit Aries Biotech at https://www.ariesbiotechnologies.org
Honored to serve as a guest speaker for the Neuroscience Roadmap Scholars Program within the Department of Neurobiology, University of Alabama at Birmingham. A link to the UAB Neuroscience Program ma
Aries Biotech is pleased to announce new hours of operation! Effective 01 October 2022, hours of operation will be Monday-Thursday, 8am to 6pm (PST) by appointment. This change will help to accommod
Increased levels of circulating amyloid beta (abeta) - 40 and -42 peptides are often increased after concussion. As such, these peptides are promising blood biomarkers of post-concussive events and n
